111 related articles for article (PubMed ID: 1949848)
41. Recombinant human gamma interferon administered by continuous intravenous infusion in acute myelogenous leukemia and myelodysplastic syndromes.
Stone RM; Spriggs DR; Arthur KA; Mayer RJ; Griffin J; Kufe DW
Am J Clin Oncol; 1993 Apr; 16(2):159-63. PubMed ID: 8452111
[TBL] [Abstract][Full Text] [Related]
42. [Clinical applications of cytokines in pediatrics].
Gadner H
Klin Padiatr; 1994; 206(1):2-11. PubMed ID: 8152201
[TBL] [Abstract][Full Text] [Related]
43. alpha-Interferon in hematological malignancies.
Giles FJ; Ozer H
Curr Opin Biotechnol; 1991 Dec; 2(6):847-50. PubMed ID: 1367959
[TBL] [Abstract][Full Text] [Related]
44. [Cytokine therapy for hematological malignancies].
Tojo A
Nihon Rinsho; 2012 Apr; 70 Suppl 2():279-84. PubMed ID: 23133968
[No Abstract] [Full Text] [Related]
45. [Contribution of cytokines in the treatment of human cancers].
Marty M; Extra JM; Dieras V
Pathol Biol (Paris); 1990 Oct; 38(8):783-5. PubMed ID: 1703291
[No Abstract] [Full Text] [Related]
46. The role of cytokines in oncology.
Lange W; Brugger W; Rosenthal FM; Kanz L; Lindemann A
Int J Cell Cloning; 1991 Jul; 9(4):252-73. PubMed ID: 1894956
[TBL] [Abstract][Full Text] [Related]
47. Clinical applications of cytokines.
Peschel C; Huber C; Aulitzky WE
Presse Med; 1994 Jun; 23(23):1083-91. PubMed ID: 7971820
[TBL] [Abstract][Full Text] [Related]
48. Cytokine therapy of neoplastic and inflammatory disease.
Aulitzky WE; Huber C; Peschel C
Int Arch Allergy Immunol; 1993; 101(3):221-6. PubMed ID: 8324383
[TBL] [Abstract][Full Text] [Related]
49. The current status of interferon alpha in haemic malignancy.
Galvani DW; Cawley JC
Blood Rev; 1990 Sep; 4(3):175-80. PubMed ID: 2245253
[TBL] [Abstract][Full Text] [Related]
50. Development and mechanisms of interferon resistance.
Kloke O; Niederle N
Cancer Treat Rev; 1990 Dec; 17 Suppl A():81-8. PubMed ID: 1709389
[No Abstract] [Full Text] [Related]
51. [Therapeutic use of cytokines].
Kliche KO; Schneider W
Versicherungsmedizin; 1993 Aug; 45(4):122-5. PubMed ID: 8379044
[TBL] [Abstract][Full Text] [Related]
52. Cytokine receptor expression in leukaemic cells.
Zola H; Siderius N; Flego L; Beckman I; Seshadri R
Leuk Res; 1994 May; 18(5):347-55. PubMed ID: 8182925
[TBL] [Abstract][Full Text] [Related]
53. [Present status and future aspects of clinical use of cytokines].
Takaku F
Nihon Rinsho; 1992 Aug; 50(8):1703-7. PubMed ID: 1433955
[No Abstract] [Full Text] [Related]
54. [Treatment of elderly patients with hematological diseases].
Imamura M
Nihon Ronen Igakkai Zasshi; 2007 Sep; 44(5):587-90. PubMed ID: 18049003
[No Abstract] [Full Text] [Related]
55. [The outlook for the clinical use of recombinant cytokines].
Ketlinskiĭ SA
Vestn Ross Akad Med Nauk; 1993; (2):11-8. PubMed ID: 7688611
[No Abstract] [Full Text] [Related]
56. Cytokines in the treatment of acute leukemias.
Ravandi F; Kebriaei P
Cancer Treat Res; 2005; 126():313-31. PubMed ID: 16209072
[No Abstract] [Full Text] [Related]
57. Problems associated with the study of cytokines in patients with leukaemia.
Preisler HD; Raza A
Eur J Cancer; 1992; 28A(6-7):1293. PubMed ID: 1627397
[No Abstract] [Full Text] [Related]
58. [Mode of action of chemotherapy of leukemia; the morphologic modifications induced by the antimitotics on normal and leukemic hemopoiesis; their biologic and clinical value].
INTROZZI P
Rev Hematol; 1955; 10(2):463-72. PubMed ID: 13255443
[No Abstract] [Full Text] [Related]
59. Pharmaceutical applications.
Curr Opin Biotechnol; 1993 Dec; 4(6):785-817. PubMed ID: 7764477
[No Abstract] [Full Text] [Related]
60. Cytokines.
Shrum JP
Clin Dermatol; 1996; 14(4):331-6. PubMed ID: 8862910
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
